Last update Feb. 5, 2024
Compatible
We do not have alternatives for アムジノシリンピボキシル ; アムジノシリン since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
アムジノシリンピボキシル ; アムジノシリン is Pivmecillinam / Mecilinam in Japanese.
Is written in other languages:アムジノシリンピボキシル ; アムジノシリン is also known as
アムジノシリンピボキシル ; アムジノシリン belongs to this group or family:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | Pivmec: 45-70; Mecilinam: ≈ 0 | % |
Molecular weight | Pivmec: 440; Mec: 325 | daltons |
Protein Binding | 5 - 10 | % |
VD | 0.2 | l/Kg |
Tmax | 1 - 1.5 | hours |
T½ | 1 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Pivmecilinam or Amdinofilin pivoxil (USA) is a prodrug of the beta-lactam antibiotic mecilinam (amdinofilin). Pivmecillinam is well absorbed from the gastrointestinal tract and is rapidly hydrolysed to the active drug mecillinam. It is indicated for the treatment of urinary tract infections. Oral administration 2 to 4 times daily.
Pivmecilinam(mecilinam has not been found in breast milk (Seiga 1977) or in such a trace amount that no effects on breastfed infants/newborns are anticipated. (Karo 223, AEMPS 2023, Knight 2019)
The manufacturer considers it compatible with breastfeeding. (Karo 223, AEMPS 2023, Knight 2019)
The oral bioavailability of mecilinam is very low, so it is administered in the form of pivmecilinam (which is well absorbed) and immediately converted to mecilinam by enzymatic hydrolysis (Roholt 1975). The little mecilinam that may pass into breast milk will not be absorbed by the infant.